468 related articles for article (PubMed ID: 27058954)
1. Amyloid Beta-Mediated Hypomethylation of Heme Oxygenase 1 Correlates with Cognitive Impairment in Alzheimer's Disease.
Sung HY; Choi BO; Jeong JH; Kong KA; Hwang J; Ahn JH
PLoS One; 2016; 11(4):e0153156. PubMed ID: 27058954
[TBL] [Abstract][Full Text] [Related]
2. Amyloid protein-mediated differential DNA methylation status regulates gene expression in Alzheimer's disease model cell line.
Sung HY; Choi EN; Ahn Jo S; Oh S; Ahn JH
Biochem Biophys Res Commun; 2011 Nov; 414(4):700-5. PubMed ID: 22001921
[TBL] [Abstract][Full Text] [Related]
3. Amyloid beta-mediated epigenetic alteration of insulin-like growth factor binding protein 3 controls cell survival in Alzheimer's disease.
Sung HY; Choi EN; Lyu D; Mook-Jung I; Ahn JH
PLoS One; 2014; 9(6):e99047. PubMed ID: 24964199
[TBL] [Abstract][Full Text] [Related]
4. ATP Binding Cassette Subfamily A Member 2 (ABCA2) Expression and Methylation are Associated with Alzheimer's Disease.
Hu W; Lin X; Zhang H; Zhao N
Med Sci Monit; 2017 Dec; 23():5851-5861. PubMed ID: 29224028
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
Liu CG; Wang JL; Li L; Wang PC
Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
[TBL] [Abstract][Full Text] [Related]
6. Altered CpG methylation in sporadic Alzheimer's disease is associated with APP and MAPT dysregulation.
Iwata A; Nagata K; Hatsuta H; Takuma H; Bundo M; Iwamoto K; Tamaoka A; Murayama S; Saido T; Tsuji S
Hum Mol Genet; 2014 Feb; 23(3):648-56. PubMed ID: 24101602
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide analysis of DNA methylation in an APP/PS1 mouse model of Alzheimer's disease.
Cong L; Jia J; Qin W; Ren Y; Sun Y
Acta Neurol Belg; 2014 Sep; 114(3):195-206. PubMed ID: 24347181
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease progression.
Wang Q; Chen Y; Readhead B; Chen K; Su Y; Reiman EM; Dudley JT
Clin Epigenetics; 2020 Dec; 12(1):189. PubMed ID: 33298155
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic modifications in Alzheimer's disease: cause or effect?
Piaceri I; Raspanti B; Tedde A; Bagnoli S; Sorbi S; Nacmias B
J Alzheimers Dis; 2015; 43(4):1169-73. PubMed ID: 25159670
[TBL] [Abstract][Full Text] [Related]
10. CRTC1 gene is differentially methylated in the human hippocampus in Alzheimer's disease.
Mendioroz M; Celarain N; Altuna M; Sánchez-Ruiz de Gordoa J; Zelaya MV; Roldán M; Rubio I; Larumbe R; Erro ME; Méndez I; Echávarri C
Alzheimers Res Ther; 2016 Apr; 8(1):15. PubMed ID: 27094739
[TBL] [Abstract][Full Text] [Related]
11. Reduced TRPC6 mRNA levels in the blood cells of patients with Alzheimer's disease and mild cognitive impairment.
Lu R; Wang J; Tao R; Wang J; Zhu T; Guo W; Sun Y; Li H; Gao Y; Zhang W; Fowler CJ; Li Q; Chen S; Wu Z; Masters CL; Zhong C; Jing N; Wang Y; Wang Y
Mol Psychiatry; 2018 Mar; 23(3):767-776. PubMed ID: 28696436
[TBL] [Abstract][Full Text] [Related]
12. PLD3 epigenetic changes in the hippocampus of Alzheimer's disease.
Blanco-Luquin I; Altuna M; Sánchez-Ruiz de Gordoa J; Urdánoz-Casado A; Roldán M; Cámara M; Zelaya V; Erro ME; Echavarri C; Mendioroz M
Clin Epigenetics; 2018 Sep; 10(1):116. PubMed ID: 30208929
[TBL] [Abstract][Full Text] [Related]
13. Neural HO-1/sterol interactions in vivo: implications for Alzheimer's disease.
Hascalovici JR; Song W; Liberman A; Vaya J; Khatib S; Holcroft C; Laferla F; Schipper HM
Neuroscience; 2014 Nov; 280():40-9. PubMed ID: 25218961
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
15. Astroglial heme oxygenase-1 and the origin of corpora amylacea in aging and degenerating neural tissues.
Song W; Zukor H; Liberman A; Kaduri S; Arvanitakis Z; Bennett DA; Schipper HM
Exp Neurol; 2014 Apr; 254():78-89. PubMed ID: 24440642
[TBL] [Abstract][Full Text] [Related]
16. Neuron-specific methylome analysis reveals epigenetic regulation and tau-related dysfunction of BRCA1 in Alzheimer's disease.
Mano T; Nagata K; Nonaka T; Tarutani A; Imamura T; Hashimoto T; Bannai T; Koshi-Mano K; Tsuchida T; Ohtomo R; Takahashi-Fujigasaki J; Yamashita S; Ohyagi Y; Yamasaki R; Tsuji S; Tamaoka A; Ikeuchi T; Saido TC; Iwatsubo T; Ushijima T; Murayama S; Hasegawa M; Iwata A
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9645-E9654. PubMed ID: 29042514
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation level of the neprilysin promoter in Alzheimer's disease brains.
Nagata K; Mano T; Murayama S; Saido TC; Iwata A
Neurosci Lett; 2018 Mar; 670():8-13. PubMed ID: 29339171
[TBL] [Abstract][Full Text] [Related]
18. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
[TBL] [Abstract][Full Text] [Related]
19. Elevation of Peripheral BDNF Promoter Methylation Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Longitudinal Study.
Xie B; Xu Y; Liu Z; Liu W; Jiang L; Zhang R; Cui D; Zhang Q; Xu S
J Alzheimers Dis; 2017; 56(1):391-401. PubMed ID: 27935556
[TBL] [Abstract][Full Text] [Related]
20. Synaptic Compensation as a Probable Cause of Prolonged Mild Cognitive Impairment in Alzheimer's Disease: Implications from a Transgenic Mouse Model of the Disease.
Baazaoui N; Flory M; Iqbal K
J Alzheimers Dis; 2017; 56(4):1385-1401. PubMed ID: 28222506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
